Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9493529 Robo1-Fc fusion protein and use thereof for treating tumours

Patent 9493529 was granted and assigned to Sanofi on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jean-Pascal Herault0

Beatrice Cameron0

Catherine Prades0

Francis Blanche0

Frederique Dol-Gleizes0

Tarik Dabdoubi0

Pierre Fons0

Date of Patent

November 15, 2016

0

Patent Application Number

136410120

Date Filed

April 8, 2011

0

Patent Citations Received

US Patent 12134633 Separation matrix

0

US Patent 11667671 Separation method

0

US Patent 11685764 Separation matrix

0

US Patent 11708390 Method of storing a separation matrix

0

US Patent 11753438 Method of cleaning and/or sanitizing a separation matrix

US Patent 11970524 Recombinant ROBO2 proteins, compositions, methods and uses thereof

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to a Robo1-Fc recombinant protein and to the use thereof for treating diseases in which a Slit protein is overexpressed, in particular cancer. The invention also relates to a composition including such a recombinant protein. Another aspect of the invention involves using a Robo1-Fc molecule as a diagnostic tool for detecting the overexpression of a molecule belonging to the Slit family in a patient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9493529 Robo1-Fc fusion protein and use thereof for treating tumours

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool